mothertobaby semaglutide pregnancy fact sheet Infographics Protecting our little ones starts

Tools for measuring individual self-care capability: a scoping review

The ESSENCE trial, published in the New England Journal of Medicine in April 2025, provides strong evidence for semaglutide (the drug in Wegovy) in fatty liver disease

Gastroparesis is a condition characterized by delayed gastric emptying, which can cause a variety of troubling symptoms, including nausea, vomiting, abdominal pain and a feeling of fullness even after consuming only a small amount of food

Various systems including polymeric hydrogels [88], nanoparticles [89] and microparticles [90] have been tested in preclinical studies

Its not just a social media trend, many women are discovering theyre more fertile after starting semaglutide

Aramchol (Galmed Pharmaceuticals) Aramchol is a novel, first in class SCD1 modulator, aiming to reduce liver fat and collagen production